<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[RSS Feed]]></title><description><![CDATA[RSS Feed]]></description><link>http://direct.ecency.com</link><image><url>http://direct.ecency.com/logo512.png</url><title>RSS Feed</title><link>http://direct.ecency.com</link></image><generator>RSS for Node</generator><lastBuildDate>Sat, 16 May 2026 05:32:46 GMT</lastBuildDate><atom:link href="http://direct.ecency.com/created/myasthenia-gravis/rss.xml" rel="self" type="application/rss+xml"/><item><title><![CDATA[Global Myasthenia Gravis Market to Gain Rapid Momentum in Coming Years: Increasing Novel Therapeutics Method Drives Growth]]></title><description><![CDATA[As per the current scenario, the global myasthenia gravis market is treading a growth path owing to the need to prevent worsening of quality of life due to myasthenia gravis. Also, there are]]></description><link>http://direct.ecency.com/pharma/@kumaralok/global-myasthenia-gravis-market-to-gain-rapid-momentum-in-coming-years-increasing-novel-therapeutics-method-drives-growth</link><guid isPermaLink="true">http://direct.ecency.com/pharma/@kumaralok/global-myasthenia-gravis-market-to-gain-rapid-momentum-in-coming-years-increasing-novel-therapeutics-method-drives-growth</guid><category><![CDATA[pharma]]></category><dc:creator><![CDATA[kumaralok]]></dc:creator><pubDate>Mon, 05 Mar 2018 07:19:18 GMT</pubDate></item></channel></rss>